Literature DB >> 23949959

Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses.

Pia Trip1, Esther J Nossent, Frances S de Man, Inge A H van den Berk, Anco Boonstra, Herman Groepenhoff, Edward M Leter, Nico Westerhof, Katrien Grünberg, Harm-Jan Bogaard, Anton Vonk-Noordegraaf.   

Abstract

A subgroup of patients with idiopathic pulmonary arterial hypertension (IPAH) has severely reduced diffusing capacity of the lung for carbon monoxide (DLCO) and poor prognosis. Their characteristics are currently unknown. The aim of this study is to contrast clinical characteristics and treatment responses of IPAH-patients with a severely reduced and more preserved DLCO. Retrospectively, 166 IPAH patients were included and grouped based on a DLCO cut-off value of 45% pred (IPAH(<45%) and IPAH(≥45%)). Clinical characteristics, treatment responses and survival were compared. IPAH(<45%) were older, more often male, had a more frequent history of coronary disease and a higher tobacco exposure. Forced expiratory volume in 1 s (FEV1), FEV1/forced vital capacity, total lung capacity and alveolar volume values were slightly lower and computed tomography scan abnormalities more prevalent in patients with a low DLCO. Age and number of pack years were independently associated with DLCO < 45% pred. IPAH(<45%) showed no different haemodynamic profile, yet worse exercise performance and a worse survival rate, which were both related to age, sex and the presence of coronary disease. To conclude, a severely reduced DLCO in IPAH is associated with advanced age and a greater tobacco exposure. These patients have a worse exercise performance despite a similar hemodynamic profile. We confirm the decreased survival in this patient group and now show that this poor outcome is related to age, sex and the presence of coronary disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949959     DOI: 10.1183/09031936.00184412

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  36 in total

1.  More on idiopathic pulmonary arterial hypertension with a low diffusing capacity.

Authors:  Karen M Olsson; Jan Fuge; Katrin Meyer; Tobias Welte; Marius M Hoeper
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  A Computational Cardiac Model for the Adaptation to Pulmonary Arterial Hypertension in the Rat.

Authors:  Reza Avazmohammadi; Emilio A Mendiola; João S Soares; David S Li; Zhiqiang Chen; Samer Merchant; Edward W Hsu; Peter Vanderslice; Richard A F Dixon; Michael S Sacks
Journal:  Ann Biomed Eng       Date:  2018-09-27       Impact factor: 3.934

3.  End-Tidal Carbon Dioxide as a Prognostic Feature in Pulmonary Arterial Hypertension.

Authors:  Caitlin E Welch; Evan L Brittain; Alexander L Newman; Ivan M Robbins; Meredith E Pugh; John H Newman; Anna R Hemnes
Journal:  Ann Am Thorac Soc       Date:  2017-06

4.  [Update pulmonary arterial hypertension : Definitions, diagnosis, therapy].

Authors:  N Sommer; M J Richter; K Tello; F Grimminger; W Seeger; H A Ghofrani; H Gall
Journal:  Internist (Berl)       Date:  2017-09       Impact factor: 0.743

5.  Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.

Authors:  Mark E Orcholski; Ke Yuan; Charlotte Rajasingh; Halley Tsai; Elya A Shamskhou; Navneet K Dhillon; Norbert F Voelkel; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-08       Impact factor: 5.464

Review 6.  Evaluation and classification of pulmonary arterial hypertension.

Authors:  Sandeep Sahay
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 7.  Obstructive Ventilatory Disorder in Heart Failure-Caused by the Heart or the Lung?

Authors:  Sergio Caravita; Jean-Luc Vachiéry
Journal:  Curr Heart Fail Rep       Date:  2016-12

Review 8.  Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors:  Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-04

9.  Structural and mechanical adaptations of right ventricle free wall myocardium to pressure overload.

Authors:  Michael R Hill; Marc A Simon; Daniela Valdez-Jasso; Will Zhang; Hunter C Champion; Michael S Sacks
Journal:  Ann Biomed Eng       Date:  2014-08-28       Impact factor: 3.934

10.  Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD.

Authors:  Aparna Balasubramanian; Todd M Kolb; Rachel L Damico; Paul M Hassoun; Meredith C McCormack; Stephen C Mathai
Journal:  Chest       Date:  2020-03-14       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.